Exploring the Therapeutic Potential of Vitamin D in Kawasaki Disease and Its Interplay with the COVID-19
Open Access
- 2 September 2024
- journal article
- review article
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 59 (5) , 432-439
Abstract
Objective: Several studies have reported outbreaks of Kawasaki disease among children amid the coronavirus disease 2019 (COVID-19) pandemic. Vitamin D possesses high utility in modulating the immune system to repair and prevent severe inflammation in COVID-19. This study aims to explore the association between Kawasaki disease and vitamin D levels in pediatric patients and describe the potential role of vitamin D in promoting recovery and preventing complications associated with Kawasaki disease in pediatric patients with COVID-19. Materials and Methods: The association between Kawasaki disease and vitamin D was explored adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, utilizing databases such as PubMed, Google Scholar, and ScienceDirect. The association between COVID-19 and Kawasaki disease was also assessed by reviewing relevant literature. Results: Most studies indicated that patients with Kawasaki disease had lower vitamin D levels. Vitamin D supplementation was also found to be deficient in the pediatric population with Kawasaki disease. Inflammation of the endothelium, cytokine storms, and endothelial dysfunction in patients suffering from COVID-19 may contribute to the development of Kawasaki disease. Vitamin D is believed to have protective potential for Kawasaki disease outcomes by modulating the inflammatory response. Conclusion: Administering vitamin D to pediatric patients with viral infections like COVID-19 is expected to accelerate clinical improvement and prevent complications from Kawasaki disease. Cite this article as: Visuddho V, Welliam Y, Maitri Aldian F, Tri Arif Sampurna M, Irzaldy A. Exploring the therapeutic potential of vitamin D in Kawasaki disease and its interplay with COVID-19. Turk Arch Pediatr.2024;59(5):432-439.Keywords
This publication has 46 references indexed in Scilit:
- Significance of serum 25-hydroxyvitamin D3 and interleukin-6 levels in immunoglobulin treatment of Kawasaki disease in childrenExperimental and Therapeutic Medicine, 2016
- 川崎病患儿25-羟基维生素D3水平变化及意义2016
- Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities?Clinical Rheumatology, 2015
- PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviewsBMC Health Services Research, 2014
- [Changes of serum 25-hydroxyvitamin D3 and interleukin-6 after treatment with intravenous immunoglobulins in children with Kawasaki disease].2014
- Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3European Journal of Pediatrics, 2014
- Autophagy in antiviral innate immunityCellular Microbiology, 2012
- Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via CathelicidinCell Host & Microbe, 2009
- Anti-inflammatory effect of 1α,25-dihydroxyvitamin D3 in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki diseaseThe Journal of Steroid Biochemistry and Molecular Biology, 2009
- NF-κB Activation in Peripheral Blood Monocytes/Macrophages and T Cells during Acute Kawasaki DiseaseClinical Immunology, 2001